All In Biotech

Drug Trial Radar · NCT07156773

The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes

Study on Safety and Clinical Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes

Last checked: Nov 19, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Sep 3, 2025

Primary completion

Mar 30, 2026

Study completion Apr 30, 2026

Sponsor

Sponsor type
Industry
First posted
Sep 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 30 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is being conducted to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of XJN010 Nasal Spray in Patients with Parkinson's Disease Experiencing Off Episodes

Conditions

  • Parkinson Disease

Interventions

  • XJN010 Nasal SprayDrug

    In the XJN010 Nasal Spray group, subjects will receive XJN010 Nasal Spray,Based on the frequency of the "off" periods experienced by Parkinson's patients.

  • PlaceboDrug

    In the XJN010 Nasal Spray blank preparation group, subjects will receive XJN010 Nasal Spray blank preparation, Based on the frequency of the "off" periods experienced by Parkinson's patients .

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MDS-UPDRS part III scoreTime frame: Day14

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital)

    Guangzhou, Guangdong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.